<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">SANP</journal-id>
      <journal-title-group>
        <journal-title>Swiss Archives of Neurology, Psychiatry and Psychotherapy</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2297-7007</issn>
      <issn pub-type="ppub">2297-6981</issn>
      <publisher>
        <publisher-name>EMH Schweizerischer Ärzteverlag AG</publisher-name>
        <publisher-loc>Farnsburgerstrasse 8
CH-4132 Muttenz</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">03132</article-id>
      <article-id pub-id-type="doi">10.4414/sanp.2020.03132</article-id>
      <article-categories>
        <!-- rubric -->
        <subj-group subj-group-type="Article Type">
          <subject>Minireview</subject>
        </subj-group>
        <!-- topics -->
        <subj-group subj-group-type="Classification">
          <subject>Extrapyramidal and movement disorders</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Erhöhtes Risiko für epileptische Anfälle bei Patienten mit idiopathischem Parkinson-Syndrom</article-title>
      </title-group>
      <contrib-group>
        <contrib id="author-1" contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Gruntz</surname>
            <given-names>Katharina</given-names>
          </name>
          <email>katharina.gruntz@gmail.com</email>
          <aff>Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology | MD | Department of Pharmaceutical Sciences, University of Basel | Spitalstrasse 26 | Basel | 4031 | SWITZERLAND</aff>
        </contrib>
        <contrib id="author-2" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Rauch</surname>
            <given-names>Marlene</given-names>
          </name>
          <email>marlenesusanne.rauch@usb.ch</email>
          <aff>Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology,
Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland</aff>
        </contrib>
        <contrib id="author-3" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Rüegg</surname>
            <given-names>Stephan</given-names>
          </name>
          <email>stephan.rueegg@usb.ch</email>
          <aff>Division of Clinical Neurophysiology, Department of Neurology, University Hospital
Basel, Basel, Switzerland</aff>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" date-type="pub" iso-8601-date="2020.10.02">
        <day>02</day>
        <month>10</month>
        <year>2020</year>
      </pub-date>
      <volume>171</volume>
      <issue>05</issue>
      <fpage>0</fpage>
      <lpage>0</lpage>
      <permissions>
        <copyright-statement>Copyright: EMH Schweizerischer Ärzteverlag AG</copyright-statement>
        <copyright-year>2020</copyright-year>
        <copyright-holder>EMH Schweizerischer Ärzteverlag AG</copyright-holder>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>"Swiss Archives of Neurology, Psychiatry and Psychotherapy" is an open access publication of EMH published in accordance with the terms of the Creative Commons licence attribution - NonCommercial - NoDerivatives 4.0 International. You are free to share, copy and redistribute the material in any medium or format under the following terms:</license-p>
          <license-p>Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.</license-p>
          <license-p>NonCommercial — You may not use the material for commercial purposes.</license-p>
          <license-p>NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.</license-p>
          <license-p>"Non-commercial" means not primarily intended for or directed towards commercial advantage or monetary compensation. The incorporation of publications in commercial products, the use of publications to advertise for commercial products or services and any other usage that directly or indirectly pursues commercial interests is subject to the express previous consent of the publishing house as part of a written agreement.</license-p>
          <license-p>Please send us your request in writing. Exact indication of the publication from which you would like to reproduce material and detailed information about its intended use help to facilitate and expedite request processing.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="article" xml:lang="en">&lt;p&gt;In 2018, we published an epidemiologic study in the Annals of Neurology describing an
increased risk of incident epileptic seizures in patients with incident Parkinson Disease
(PD). Previous literature on the association between PD and epilepsy was sparse and
conflicting. Our study was the first to investigate the risk of incident epileptic
seizures in association with PD using a large population-based dataset with long followup.&lt;/p&gt;</abstract>
    </article-meta>
  </front>
  <body/>
  <back/>
</article>
